Get the app!
Back to Trades

Matsuda Masaru

EVPChief Legal OfficerCIK 0001798679

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
12
Buy transactions
0
Sell transactions
22
Companies
1
Active
2025–2026

Matsuda Masaru, EVP, Chief Legal Officer, has filed 12 SEC reports (2025–2026), all concentrated in Arcutis Biotherapeutics, Inc. (ARQT), totaling $7.2M in disclosed volume. Weighing $0 bought versus $4.3M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

12 loaded
Nov 4ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruEVP, Chief Legal OfficerSell$1.4M
Sep 18ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$91.9K
Sep 10ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$250.0K
Aug 5ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$32.1K
May 6ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$192.4K
Mar 3ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$313.9K
Feb 4ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$1.0M
Dec 3ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$50.1K
Nov 21ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$72.1K
Nov 5ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$178.2K
Sep 8ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$583.7K
Aug 5ARQT
Arcutis Biotherapeutics, Inc.
Matsuda MasaruSee RemarksSell$90.7K

12 filings